Assessment of Additional Consolidation Chemotherapy Effects in Patients with Acute Myeloid Leukemia before Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Ghavamzadeh, Ardeshir [1 ]
Moghaddam, K. Ali [1 ]
Vaezi, M. [1 ]
Zafari, Y. [1 ]
Maheriazar, R. [1 ]
Mousavi, A. [1 ]
Bahar, B. [1 ]
Jahani, M. [1 ]
机构：
[1] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.453
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
407
引用
收藏
页码：S285 / S286
页数：2
相关论文
共 50 条
  • [21] Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission
    Lee, Yoo Jin
    Baek, Dong Won
    Ahn, Jae-Sook
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung Joon
    Ham, Ji Yeon
    Suh, Jang Soo
    Sohn, Sang Kyun
    Moon, Joon Ho
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (12): : E527 - E533
  • [22] Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients
    Ciftciler, Rafiye
    Demiroglu, Haluk
    Buyukasik, Yahya
    Okay, Mufide
    Aksu, Salih
    Sayinalp, Nigun
    Malkan, Umit Yavuz
    Haznedaroglu, Ibrahim Celalettin
    Ozcebe, Osman
    Goker, Hakan
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (06) : 752 - 755
  • [23] Outcomes of Patients with Acute Myeloid Leukemia Receiving a Second Allogeneic Stem Cell Transplantation
    Ussmann, Jule
    Bischof, Lara
    Brauer, Dominic
    Backhaus, Donata
    Herling, Marco
    Metzeler, Klaus H.
    Merz, Maximilian
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Platzbecker, Uwe
    Schwind, Sebastian
    Jentzsch, Madlen
    BLOOD, 2022, 140 : 4819 - 4820
  • [24] THE TIME FACTOR AND THE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Parovichnikova, E. N.
    Kuzmina, L. A.
    Vasilyeva, V. A.
    Pokrovskaya, O. S.
    Drokov, M. Yu.
    Lukyanova, I. A.
    Fidarova, Z. T.
    Gaponova, T. V.
    Troitskaya, V. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2024, 69 (03): : 276 - 284
  • [25] Prognostic Value of Minimal Residual Disease before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
    Perez-Lopez, Olga
    Caballero-Velazquez, Teresa
    Colado, Enrique
    Alonso, Sara
    Gonzalez-Campos, Jose
    Prats-Martin, Concepcion
    Rodriguez-Torres, Nancy
    Escamilla Gomez, Virginia
    Espigado, Ildefonso
    Antonio Perez-Simon, Jose
    BLOOD, 2018, 132
  • [26] Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients
    Jackson, Kathryn
    Kennedy, Glen
    Mollee, Peter
    Marlton, Paula
    Morris, Kirk
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 246 - 254
  • [27] Indications for allogeneic stem cell transplantation 2017: acute myeloid leukemia
    Roellig, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 116 - +
  • [28] Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and HIV Infection
    Schneidawind, D.
    Dorn, C.
    Faul, C.
    Vogel, W.
    Berg, C.
    Beck, R.
    Korn, K.
    Dittmann, H.
    Schleicher, J.
    Erbersdobler, A.
    Jahn, G.
    Kanz, L.
    Bethge, W.
    TRANSFUSIONSMEDIZIN, 2012, 2 (02) : 90 - 93
  • [29] Acute myeloid leukemia of donor cell origin after allogeneic stem cell transplantation in a patient with acute myeloid leukemia
    Hindilerden, F.
    Kantarcioglu, B.
    Guvenc, S.
    Goksoy, H. S.
    Buyukdogan, M.
    Ozcelik, T.
    Kucukkaya, R. Diz
    Arat, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5610 - 5610
  • [30] Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
    Bohm, A.
    Rabitsch, W.
    Greinix, H. T.
    Kalhs, P.
    Mitterbauer, M.
    Schulenburg, A.
    Wohrer, S.
    Worel, N.
    Strunk, D.
    Linkesch, W.
    Urban, C.
    Schwinger, W.
    Peters, C.
    Gastl, G.
    Nachbaur, D.
    Kircher, B.
    Clausen, J.
    Auberger, J.
    Krieger, O.
    Kasparu, H.
    Hauser, H.
    Machherndl-Spandl, S.
    Weltermann, A.
    Lindner, B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S183 - S183
12345